Hawk Ridge Capital Management LP Ani Pharmaceuticals Inc Transaction History

Hawk Ridge Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $5.89 Million - $9.85 Million	-196,661 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$30.35 - $67.14 $239,765 - $530,406	7,900 Added 4.19%	196,661 $8.01 Million
Q4 2019 Feb 14, 2020	BUY	$55.65 - $79.83 $1.88 Million - $2.7 Million	33,800 Added 21.81%	188,761 $3.55 Million
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $2.03 Million - $2.68 Million	31,400 Added 25.41%	154,961 $11.3 Million
Q1 2019 May 15, 2019	BUY	$45.83 - $70.54 $5.66 Million - $8.72 Million	123,561 New	123,561 $8.72 Million

215

19.1M

3.4K

10.8K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.21B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Hawk Ridge Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hawk Ridge Capital Management LP with notifications on news.